Skip to content

What is Cardiplot used for? A Guide to Manidipine

4 min read

According to extensive research, Cardiplot, a brand name for the medication Manidipine, is a third-generation calcium channel blocker primarily used to treat mild to moderate essential hypertension, or high blood pressure. Its ability to effectively reduce blood pressure with a sustained effect can be a valuable tool in managing cardiovascular risk.

Quick Summary

Cardiplot contains manidipine, a dihydropyridine calcium channel blocker that relaxes blood vessels to lower blood pressure. It is used to manage mild to moderate hypertension and offers a favorable tolerability profile compared to other similar medications.

Key Points

  • Brand Name and Active Ingredient: Cardiplot is a brand name for the medication manidipine hydrochloride.

  • Treatment for Hypertension: Its primary use is for managing mild to moderate essential hypertension (high blood pressure).

  • Mechanism of Action: It is a calcium channel blocker that works by relaxing and widening blood vessels to lower blood pressure.

  • Favorable Tolerability: Studies suggest manidipine has a lower incidence of peripheral edema (ankle swelling) compared to other calcium channel blockers like amlodipine.

  • Potential Renal Benefits: The medication may offer a protective effect on renal function and is beneficial for hypertensive patients with conditions like diabetes.

  • Once-Daily Dosing: Its prolonged action provides sustained blood pressure reduction for 24 hours, allowing for convenient once-daily administration.

In This Article

Cardiplot is a prescription medication belonging to a class of drugs known as calcium channel blockers. Specifically, its active ingredient, manidipine hydrochloride, is a third-generation dihydropyridine calcium channel blocker. This medication plays a crucial role in managing chronic health conditions by targeting the smooth muscle cells of blood vessels to promote vasodilation. A healthcare provider typically prescribes Cardiplot as part of a long-term treatment plan to control hypertension and prevent related complications.

What is Cardiplot (Manidipine)?

Cardiplot is a brand name for the medication manidipine, which has been used clinically since 1990. As a calcium channel blocker, its primary function is to prevent calcium from entering the muscle cells of the heart and blood vessels. By blocking these L-type calcium channels, manidipine causes the blood vessels to relax and widen. This process, known as vasodilation, reduces the resistance that the heart has to pump against, thereby lowering blood pressure throughout the body.

Manidipine's prolonged action is one of its notable features, potentially ensuring a sustained blood pressure reduction over a full 24-hour period with just one daily dose. This can help provide consistent control for patients with essential hypertension and may lead to better treatment adherence.

How Cardiplot Works: Mechanism of Action

Cardiplot's mechanism of action is centered on its function as a calcium antagonist. The detailed process involves:

  • Blocking Calcium Channels: The drug inhibits the influx of calcium ions into vascular smooth muscle cells and cardiac myocytes by targeting L-type calcium channels.
  • Promoting Vasodilation: By preventing calcium from entering these cells, Cardiplot inhibits their contraction, causing the blood vessels to relax and expand. This reduces peripheral vascular resistance.
  • Lowering Blood Pressure: The reduced resistance makes it easier for the heart to pump blood, which in turn lowers overall blood pressure.
  • Renal Selectivity: Unlike some other calcium channel blockers, manidipine has a degree of selectivity for the kidney arterioles, meaning it may also offer a protective effect on renal function. It promotes diuresis and reduces intraglomerular pressure, which can be beneficial for hypertensive patients, particularly those with conditions like diabetes.

Primary Uses of Cardiplot

The main therapeutic indication for Cardiplot is the treatment of mild to moderate essential hypertension. It is typically administered once daily and is designed to provide long-term control of high blood pressure. By helping to keep blood pressure within a healthy range, Cardiplot can contribute to reducing the risk of serious cardiovascular events, including heart attacks and strokes.

While primarily used for hypertension, research has also explored manidipine's potential benefits for patients with specific comorbidities, such as type 2 diabetes and chronic kidney disease, due to its favorable renal effects.

Administration

The administration of Cardiplot is determined by a healthcare provider and can vary depending on the patient's condition and response to treatment.

  • The medication is typically taken once daily.
  • Dosage adjustments may be necessary based on individual needs and response.
  • Lower starting doses might be recommended for elderly patients or individuals with mild hepatic impairment.

Important Administration Information

  • Take the tablet with a little liquid, without chewing.
  • Do not abruptly stop taking the medication, as this can lead to a hypertensive crisis.
  • Avoid consuming grapefruit or grapefruit juice, as it can significantly increase the drug's effect.

Side Effects and Safety Considerations

Like all medications, Cardiplot can cause side effects. Many are related to its vasodilatory effects and are often mild and transient, though some can be more serious.

Common Side Effects

  • Headache
  • Dizziness or vertigo
  • Flushing (hot flushes)
  • Palpitations (irregular or fast heartbeat)
  • Peripheral edema (swelling of the ankles or feet)
  • Gastrointestinal issues (nausea, constipation)
  • Fatigue

Serious Side Effects

  • Hypersensitivity reaction: Seek immediate medical attention if you experience rash, itching, or swelling.
  • Severe hypotension: Excessive peripheral vasodilation from overdose can cause a significant drop in blood pressure.
  • Contraindications: Do not use if you have severe renal or hepatic failure, unstable angina, untreated congestive heart failure, or within four weeks of a myocardial infarction.

Cardiplot vs. Other Calcium Channel Blockers

Cardiplot (manidipine) belongs to the dihydropyridine subclass of calcium channel blockers, alongside widely prescribed drugs like amlodipine. While they share a similar mechanism of action, studies have shown some key differences, particularly concerning side effects like peripheral edema.

Feature Cardiplot (Manidipine) Other CCBs (e.g., Amlodipine)
Incidence of Ankle Edema Lower incidence reported Higher incidence reported
Efficacy Similar efficacy in reducing systolic and diastolic blood pressure Similar efficacy in reducing systolic and diastolic blood pressure
Renal Effects Shown to have positive renal effects and potential renal protection Effects vary; some CCBs do not offer the same level of renal protection
Mechanism Targets L-type calcium channels to cause vasodilation Targets L-type calcium channels to cause vasodilation
Primary Use Mild to moderate essential hypertension Hypertension and angina

Conclusion

Cardiplot, with its active ingredient manidipine, is an effective and well-tolerated medication for the treatment of mild to moderate essential hypertension. Its mechanism of action, involving the blocking of L-type calcium channels, provides sustained blood pressure control over 24 hours. A key differentiating factor is its potential for better tolerability, particularly a lower incidence of ankle edema compared to other widely used calcium channel blockers like amlodipine. Cardiplot also offers a degree of renal protection, which can be particularly beneficial for patients with comorbidities. As with any prescription medication, it is crucial to follow the guidance of a healthcare professional to ensure safe and effective use, especially considering its contraindications and potential interactions with other drugs and food products.

Frequently Asked Questions

The active ingredient in Cardiplot is manidipine hydrochloride, a medication that belongs to the class of calcium channel blockers.

Cardiplot is typically taken once daily, often in the morning. The specific timing and amount should be determined by a healthcare professional based on your individual needs.

While peripheral edema (ankle swelling) is a known side effect of many calcium channel blockers, studies indicate that Cardiplot (manidipine) has a lower potential for causing this side effect compared to medications like amlodipine.

You should avoid consuming grapefruit and grapefruit juice while taking Cardiplot, as it can inhibit the metabolism of manidipine and enhance its blood-pressure-lowering effect.

Dosage adjustments may be necessary for patients with impaired kidney or liver function. Cardiplot is contraindicated in cases of severe renal or liver failure.

Both are calcium channel blockers used for hypertension and have similar efficacy in lowering blood pressure. However, manidipine (Cardiplot) has been shown to have a lower incidence of peripheral edema and some protective renal effects compared to amlodipine.

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed one and continue with your regular schedule. Do not double up doses.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.